Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromelain vs Calcium Hydroxide for Postoperative Pain and Bacterial Load in Necrotic Premolars
NCT05687760Phase 1Unknown
- Sponsor
- Cairo University
- Start
- Feb 2023
- Primary completion
- Feb 2023
- Modality
- Replacement Enzymes
01
Overview
Phase 1, randomised, single-blind trial of bromelain in pulp necrosis and apical periodontitis (AP), sponsored by Cairo University. Primary endpoint: Postoperative pain intensity at 6 hours. Status: unknown.
02
Drugs
bromelain
03
Conditions
pulp necrosisapical periodontitis (AP)
Beyond the preview
Go deeper on NCT05687760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05687760.